
|Articles|May 1, 2002
Tacrolimus ointment not associated with skin cancer risk
Theory on cutaneous immune responses led to long-term safety trials and reassuring answer
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5











